Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical Misses on EPS, Stock Up 0.52%

Collegium Pharmaceutical reported a larger-than-expected loss per share, which typically raises concerns among investors. However, the stock saw a slight increase of 0.52%, indicating that investors may have had lower expectations or are optimistic about future developments. The lack of revenue data and management commentary leaves some uncertainty about the company's performance and direction.